Impella saves lives in STEMI with shock, but with major risks (DanGer Shock)

What’s more dangerous than an Impella? Cardiogenic shock

Patients with acute ST-elevation myocardial infarction with cardiogenic shock treated with the Impella CP flow pump for mechanical circulatory support had increased survival at 6 months compared to those receiving standard care, the DanGer Shock randomized trial showed.

The results were a redemption of sorts for the Impella device, some models of which (…